At present,China is in an important stage of supply side structural reform.Many enterprises hope to enhance the control of the upstream and downstream industrial chain through M&A,and then obtain long-term and stable development of enterprises.Under the guidance of national industrial policy and the promotion of market economy environment,a new round of M&A a wave is set off in China.As a financial innovation mode under the new situation,"listed company+PE" M&A fund is favored by more and more enterprises for its advantages of high efficiency,obvious synergy and exit channel locking.However,compared with foreign capital market,the mode of setting up industrial merger and acquisition fund by Listed Companies in China is still in the exploration stage,so it is still of great significance to improve the research of industrial merger and acquisition fund under this mode through the combination of theoretical analysis and case study.Boya biology is not only representative in the biomedical manufacturing industry,but also has set up three industry merger and acquisition funds together with the controlling shareholder gotejia group and its subsidiaries since 2015,successfully completed the first project merger and acquisition to enable the fund to exit smoothly,so this case has a strong representative.Listed in this paper,based on "company+PE" type of mergers and acquisitions fund related literature and theory research and discrimination on the basis of the concept,combined with national policies background,introduced detailed analyzes the reason of boya biological fund set up m&a and the actual operation situation of the fund,respectively from the market price,financial indicators and non-financial indicators based on the comprehensive performance of Angle to analyze the effect after boya biological set up industry mergers and acquisitions fund,and at the end of this article in view of the bm biological defects in the process of implementation of mergers and acquisitions fund suggested that the relevant conclusions,hopes for the future proposed buy-out funds of the listed company to provide some reference. |